Mefatinib is a potent oral tyrosine kinase inhibitor of the quinazoline class, primarily utilized in the treatment of non-small cell lung cancer and other solid tumors by targeting receptor tyrosine kinases… Read more

















Mefatinib is a potent oral tyrosine kinase inhibitor of the quinazoline class, primarily utilized in the treatment of non-small cell lung cancer and other solid tumors by targeting receptor tyrosine kinases like EGFR and MET. This category features an essential selection of Mefatinib reference standards, including the malate salt, Z/E isomers, and various related degradation products. Pharmaceutical laboratories rely on these materials for comprehensive impurity profiling and rigorous quality control protocols during drug development. The collection includes specific impurities such as nitroso derivatives and hydroxyquinazoline precursors, which are vital for identifying and quantifying potential by-products in manufacturing. Additionally, stable isotope labelled Mefatinib compounds are available to serve as high-quality internal standards for method validation and bioanalytical assays, ensuring accuracy and precision in complex liquid chromatography workflows when assessing drug purity and stability.